An efficient sensitization for TRAIL-induced apoptosis of either TRAIL resistant or TRAIL sensitive melanoma cell lines was also achieved by the combination with BMS-345541 [IκB kinase (IKKβ) inhibitor]; the synergistic effects can be explained by the activation of Bid by TRAIL and of Bax by BMS-345541. Here, BID is linked to melanoma.